PPARα Agonist, MHY3200, Alleviates Renal Inflammation during Aging via Regulating ROS/Akt/FoxO1 Signaling
Abstract
Share and Cite
Kim, M.J.; Kim, D.H.; Bang, E.; Noh, S.G.; Chun, P.; Yokozawa, T.; Moon, H.R.; Chung, H.Y. PPARα Agonist, MHY3200, Alleviates Renal Inflammation during Aging via Regulating ROS/Akt/FoxO1 Signaling. Molecules 2021, 26, 3197. https://doi.org/10.3390/molecules26113197
Kim MJ, Kim DH, Bang E, Noh SG, Chun P, Yokozawa T, Moon HR, Chung HY. PPARα Agonist, MHY3200, Alleviates Renal Inflammation during Aging via Regulating ROS/Akt/FoxO1 Signaling. Molecules. 2021; 26(11):3197. https://doi.org/10.3390/molecules26113197
Chicago/Turabian StyleKim, Min Jo, Dae Hyun Kim, EunJin Bang, Sang Gyun Noh, Pusoon Chun, Takako Yokozawa, Hyung Ryong Moon, and Hae Young Chung. 2021. "PPARα Agonist, MHY3200, Alleviates Renal Inflammation during Aging via Regulating ROS/Akt/FoxO1 Signaling" Molecules 26, no. 11: 3197. https://doi.org/10.3390/molecules26113197
APA StyleKim, M. J., Kim, D. H., Bang, E., Noh, S. G., Chun, P., Yokozawa, T., Moon, H. R., & Chung, H. Y. (2021). PPARα Agonist, MHY3200, Alleviates Renal Inflammation during Aging via Regulating ROS/Akt/FoxO1 Signaling. Molecules, 26(11), 3197. https://doi.org/10.3390/molecules26113197

